ДЕ ВИЛЬДЕ Маттеус Корнелис (NL),СЕЙБЕН Йоханнес Вильхельмус Кристина (NL),КАМПХЕЙС Патрик Йозеф Герардус Хендрикус (NL),ХАГЕМАН Роберт Йохан Йозеф (NL)
申请号：
RU2013145701/15
公开号：
RU2013145701A
申请日:
2012.03.14
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. A composition comprising: i) one or more of uridine and cytidine, and their salts, phosphates, acyl derivatives or esters thereof ii) a lipid fraction comprising at least one of docosahexaenoic acid (22: 6 DHA), eicosapentaenoic acid (20: 5 EPA) and docosapentaenoic acid (22: 5 DPA) or esters thereof, wherein the lipid fraction comprises less than 2 wt% α-linolenic acid (ALA), based on the weight of all fatty acids iii. ) choline or its salts and esters, wherein said composition further comprises at least one vitamin complex and B for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsy and spinal mozga.2. A composition according to claim 1 for use in the prevention or treatment of damage to the spinal mozga.3. A composition according to claim 1 or 2, wherein said lipid fraction comprises medium-chain fatty acids (MCT), and wherein the ratio of the total amount of MCT C6: 0 + C7: 0 + C8: 0 to total C9: 0 and C10: 0 is smaller than 2: 1.4. A composition according to claim 1 or 2, wherein said lipid fraction comprises less than 2 wt.% Of fatty acids having less than 14 carbon atoms based on total fatty kislot.5. A composition according to claim 1 or 2, further comprising less than 25 mg total quantity of cystine and taurine in 100 ml kompozitsii.6. A composition according to claim 1 or 2, wherein linoleic acid (LA) is present in an amount less than 15 g / 100 g fatty kislot.7. A composition according to claim 1 or 2, further comprising at least one vitamin B, selected from the group consisting of vitamin B6, vitamin B9 and vitamin B12 or their equivalents, preferably comprising vitamin B6, B9 and V12.8. A composition according to claim 1 or 2, wherein said lipid Fr.1. Композиция, содержащая:i) один или более из уридина и цитидина, или их солей, фосфатов, ацильных производных или сложных эфировii) липидную фракцию, содержащую по меньшей мере одну из докозагексаеновой кислоты (22:6 DHA), эйкозапентаеновой кислоты (20:5 EPA) и доко
